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MISSION  
 
The mission of the National Institute on Drug Abuse is to lead the nation in bringing the 
power of science to bear on drug abuse and addiction.  This charge has two critical 
components: The first is the strategic support and conduct of research across a broad range 
of disciplines.  The second is to ensure the rapid and effective dissemination and use of the 
results of that research to significantly improve drug abuse and addiction prevention, 
treatment, and policy.  
 
OVERVIEW OF NIDA’S STRATEGY FOR ADDRESSING HEALTH DISPARITIES 
 
Unlike other diseases, drug addiction poses many peculiar challenges to health researchers, 
providers, and public health officials in the search for effective prevention and treatment 
strategies and policies. These challenges emanate primarily from the fact that drug abuse 
and addiction are usually the result of illegal activity and drug abusers are often viewed as 
morally corrupt or weak-willed individuals who engage in not only voluntary self and 
socially destructive behavior but also criminal activity. In short, despite the fact that we 
know unequivocally that addiction is a disease like any other medical disease, it remains a 
stigmatized disease. And this stigma spills over to all aspects of drug abuse research, 
prevention and treatment (e.g., obtaining measures of use, safety and legal concerns, early 
intervention is compromised by efforts to hide the disease, and denial of dependency).  
 
Racial/Ethnic minority populations are perhaps most adversely affected by this stigma and 
its effects leading to misperceptions about drug abuse and addiction in minority 
communities and the way in which prevention and treatment are delivered to them. For 
example, the common perception is that minority groups, particularly Blacks and Hispanics, 
use drugs more than whites even though epidemiologic data show little difference in overall 
use by race/ethnicity. In fact, in some instances minority groups are less likely to use licit or 
illicit drugs. There are, however, great differences in the consequences of drug use for 
racial/ethnic minorities creating a great need to better understand the unique prevention, 
treatment and health services needs of these communities.  
 
NIDA has made a concerted effort, particularly over the last eight years, to better understand 
and address the drug abuse and addiction research needs of racial/ethnic populations 
focusing on research areas where there are significant gaps in knowledge and /or clear 
disparities in prevention and treatment. In 1993, NIDA established a Special Populations 
Office, which has two overall goals: (1) to encourage increased research on drug abuse in 
minority populations in NIDA divisions and (2) to encourage and enable increased minority 
participation in drug abuse research. Moreover, NIDA formed an institute-wide work group, 
the Consortium on Minority Concerns, which meets monthly to address research and 
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research development issues of concern to minority populations. Each program division and 
office is represented on the Consortium.  
 
Several institute-wide initiatives and policies were implemented which has led to progress in 
research that addresses health disparities and the under-representation of minority scholars 
in drug abuse research. Some of these initiatives include:  
 
Historically Black Colleges and Universities (HBCU) Initiative. This was 
designed to encourage HBCUs to become involved in drug abuse research and to 
assist them in developing the capacity to conduct drug abuse research. Some selected 
outcomes of this initiative include: increased support of HBCUs through the NIH 
competitive process (which has led to research on under-researched areas such as 
developing prevention programs for rural African American youth, understanding 
risk for drug abuse in African American youth at developmental transition points), 
the establishment of a center on drug abuse research at Howard University (which 
has since received a substance abuse grant from the Robert Wood Johnson 
Foundation), support of an established research scientist cooperative agreement 
program at four HBCUs in collaboration with the National Center on Minority 
Health and Health Disparities (NCMHD), formerly the Office of Research on 
Minority Health,  (North Carolina Central has recruited a distinguished NIDA 
scientist with three independent awards -  this has already led to collaborations for 
student and faculty research and training opportunities with Wake Forest University 
and UNC), and increased activity on the campuses around substance abuse 
awareness and prevention.  
 
Enhancement of the Underrepresented Minority Supplement Program. NIDA 
instituted a new policy for the receipt, review and funding of minority supplement 
applications. In the last eight years, NIDA has more than doubled its support of 
Minority Supplements in amount of funds allocated yearly to the program and nearly 
doubled the number of new awards made (from FY 1994 to FY 2000). NIDA also 
established a policy to include Asians and Pacific Islanders in behavioral and clinical 
work because they are underrepresented in these areas of drug abuse research. 
Former recipients are applying for and receiving independent research awards, and 
often these recipients focus on disparities research issues and/or intend to mentor 
other underrepresented students and scholars.  
 
Summer Research with NIDA. To address concerns about the insufficient pipeline 
of minority researchers, NIDA established a summer program to place minority high 
school and undergraduate students with extramural scientists. Response has been 
very positive from students and investigators. Initially started with NCMHD funds, 
NIDA completely supports the program now.  Approximately 35 – 40 students are 
placed each summer, some of them returning to the same investigators.  
 
Minority Recruitment and Training Program. This is an intramural summer 
research program for students and faculty. It accepts minority high school, college, 
graduate and medical students, and faculty members. About 25 students are placed 
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each summer. A successful minority student development program at Temple 
University requested that some of their students be placed with NIDA's intramural 
program based on the reputation of this program and its director.  
 
Minority Work Groups. Work groups comprised of experts in substance abuse and 
addiction or health concerns of minority populations have been created. These Work 
Groups advise the NIDA Director on research and research development needs of the 
particular minority communities that will lead to effective prevention and treatment 
approaches for each group. Work groups exist for African American, Hispanic, 
Asian Pacific Islander, and Native American/Alaska Native communities. Some 
outcomes of the work of these groups include new PIs, identification of candidates 
for the supplement program, new opportunities for NIDA to interact with 
professional and community groups, new ideas for research, new study section 
members, and increased mentoring and collaboration among group members.   
 
Development of PAs and RFAs. NIDA released a new program announcement, 
Minority Institution's Drug Abuse Research Program, to support minority institutions 
wishing to develop their capacity to conduct drug abuse research. Two new programs 
recently funded under this PA focus on Hispanic issues in drug abuse. An RFA, the 
HBCU Cooperative Agreement, was released in collaboration with the NCMHD. 
Four projects were funded under this RFA: one focuses on prevention interventions 
with urban African American youth and one focuses on epidemiology and prevention 
issues in minority populations. All include research training opportunities for 
minority faculty and students.  
 
Research Development Technical Assistance Workshops. NIDA offers technical 
assistance to minority scholars on developing research studies in drug abuse and 
addiction. Participants are provided information on conceptual and methodological 
concerns in drug abuse and addiction research in addition to information on the NIH 
grants application and review processes.  Participants in this program have become 
NIDA/NIH grantees, NIH peer reviewers, and grantees of other agencies and 
foundations. 
 
As a result of these activities and individual division activities, NIDA has experienced 
approximately a 97% growth in minority researchers since FY 1993. With this growth in 
minority researchers (although all are not involved in minority focused research) and an 
intense focus on drug use and addiction in minority communities, we have observed an 
increase in applications and awards that focus on drug abuse disparities and needs in 
minority communities.  
 
This proposed strategic plan reflects NIDA's insights and knowledge gained from our efforts 
to address health disparities among racial/ethnic groups over the last few years. In addition, 
the plan incorporates the recommendations made by the expert work groups described above 
and an extensive review of NIDA's research programs and activities conducted by staff. 
Public comments received were also considered and incorporated into the plan.   
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Over the next five years, NIDA will strive to: (1) improve our understanding of the 
incidence and causes of drug abuse and addiction in all racial/ethnic groups recognizing the 
diversity by gender, SES, and other factors within racial/ethnic populations, (2) strengthen 
and expand the community and research infrastructure for conducting research within 
racial/ethnic populations, (3) improve prevention and treatment for racial/ethnic groups at 
highest risk for addiction and medical consequences of drug use and addiction, and (4) 
widely disseminate information on drug use and the disease of addiction in racial/ethnic 
communities identifying best approaches to prevention and treatment. 
 
In 2000, NIDA established a Health Disparities Committee, comprised of staff from all of 
NIDA’s programs including the budget office and intramural program, to develop its 
Strategic Plan to Address Health Disparities. This committee was made a continuing 
committee by the Director to oversee the implementation of the strategic plan.  As part of its 
work, the committee establishes institute-wide priorities, stimulates interest, and develops 
support for the goals and activities of the plan. This committee is chaired by staff of the 
Special Populations Office and reports to the Director of the institute.   In addition, NIDA’s 
National Advisory Council has a Health Disparities Subcommittee to monitor activities 
related to our strategic plan. The Special Populations Office meets with the Council 
Subcommittee at each regular Council meeting.   
 
  
 
GOAL 1. RESEARCH  
 
Research Area of Emphasis 1.  Epidemiology of Drug Abuse, Health Consequences and 
Infectious Diseases among Minority Populations 
 
Rationale and Priority 
 
This is our first research priority. 
 
Our understanding of drug use and addiction in racial/ethnic minority populations and the 
disparities resulting from drug abuse and addiction is limited.  Over the next five years, we 
want to improve our understanding of the incidence and causes of drug abuse and addiction 
and its consequences in all racial/ethnic groups recognizing the diversity by gender, SES, 
and other factors within racial/ethnic populations.  Aggressively pursuing research in this 
area will strengthen the discovery of better, more appropriate prevention and treatment 
strategies with racial/ethnic populations.   
 
Having a good knowledge base on the incidence and patterns of drug use, abuse, and 
addiction is critical to assessing the need for and shaping the content of prevention and 
treatment programs. Current surveys such as the NIDA-supported Monitoring the Future 
study (a national survey of 8th, 10th, and 12th graders) and the SAMHSA-supported 
National Household Survey on Drug Abuse (NHSDA -- a national survey of persons 12 and 
older residing in households) provide important information on drug use patterns and trends. 
However, they are limited in the extent to which they reveal in-depth information about 
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racial/ethnic groups. For example, neither survey has adequate representation of Native 
Americans, Alaska Natives, Asians, or Pacific Islanders. Although this may change 
beginning with the increased sample size in the 1999 NHSDA survey, there is still concern 
about obtaining adequate adolescent samples for these subgroups. African Americans and 
Hispanics are included, but their numbers are not sufficient to form reliable subgroups to 
investigate within group profiles, e.g., develop separate profiles for Mexicans and Puerto 
Ricans. Moreover, there are selection biases that disproportionately affect minorities that 
may suppress their numbers in these general surveys. For example, Hispanics have a higher 
school drop-out rate than other groups and therefore may be more likely to be excluded from 
the school surveys and may be difficult to reach in household surveys. Since dropout rates 
correlate with higher risk for deviant behavior, we may be missing information on a group 
with a high risk for drug abuse and addiction. 
 
More work is needed to better understand the causes of drug use in minority communities. 
Promising studies are underway on risk and protective factors especially on the role of 
culture, religiosity, ethnic identity, family, peer, and environmental/community level factors 
in drug initiation. For example, minority youth tend to initiate drug use later than white 
youth. Yet, when African Americans start using, they seem to progress to addiction faster. 
Among Hispanic youth, drug use seems to increase with increased acculturation to US 
norms and with years and generations in the US. We know little about predictors of use in 
Pacific Islander and Asian subpopulations.  
 
Better measures and designs are needed to appropriately assess drug abuse and addiction and 
related behaviors in racial/ethnic populations. 
 
Minority populations are disproportionately affected by HIV/AIDS and other infectious 
diseases that are a consequence of using drugs and engaging in other risky behaviors. 
African Americans and Hispanics, especially women, comprised 54.7% of the AIDS cases 
reported to CDC in 1998. This percentage is far greater than their representation in the 
general population. Other studies indicate a plethora of ways in which minorities may be 
adversely affected by drug abuse-related diseases: women, particularly African American 
women, are at higher, unique risk for HIV/AIDS; injection drug users are at increased risk 
for mycobacterium tuberculosis infection and Hepatitis B and C infection; there is possibly 
an association between vascular injury of the neonatal central nervous system and the level 
of prenatal cocaine exposure; and Hispanic homeless are more likely to share needles. We 
know relatively little about the varying patterns of initiation of drug use and addiction 
among women of diverse racial and ethnic groups. 
 
NIDA has continuously attempted to be responsive to the need to understand the patterns 
and causes of drug abuse in all populations through a number of activities such as releasing 
program announcements and requests for applications and convening conferences and 
meetings. For example, in 1998 NIDA reissued its "Epidemiologic Research on Drug 
Abuse" PA which encourages a number of epidemiologic strategies including monitoring of 
trends over time of drugs of use/abuse, identification and measurement of health problems 
associated with drug abuse, and international epidemiology of drug abuse. Applications 
submitted in response to this PA are expected to guide the development of interventions, 
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define subpopulations, identify groups at risk for various health conditions such as HIV, TB, 
hepatitis, poor pregnancy outcomes, ADHD, mental disorder, and other conditions 
(predisposing and consequential to drug use/abuse), inform and influence local state and 
federal health agencies, and provide guidance for public policy. Investigators have been 
strongly encouraged to conduct analyses by race/ethnicity.  
 
NIDA staff have been working actively at numerous meetings to increase the number of 
grant applications in such areas as HIV in the African American population, health 
care/primary care access and utilization among minority drug abusers with HIV infections, 
and epidemiology of HIV in the Caribbean. 
 
Objective 1:  Improve the knowledge base on the patterns and origins of drug abuse and 
addiction in all racial/ethnic populations including producing estimates of racial disparities 
on the incidence and prevalence of drug use and addiction within those populations, 
examining both risk and protective factors. 
 
  Action Plan  
        Expand research to:  
 
Assess, within and across racial/ethnic groups, the magnitude, incidence and                           
prevalence of drug abuse analyzing by gender.  
 
Identify and assess both individual and community/environmental 
vulnerability, risk and protective factors for drug use and abuse and related 
consequences in    various racial/ethnic populations analyzing by gender.  
 
Develop better sampling methods for hard-to-reach minority populations and 
more effective ways to reduce survey non-response and increase the validity 
of self-reported drug use and associated behaviors.  
 
Support the secondary analysis of data obtained under NIH-supported 
research pertinent to understanding the epidemiology and etiology of drug 
abuse in racial/ethnic populations including analyses by gender. 
 
Primary Outcome Measure.  The primary outcome measure is to greatly 
increase the scientific knowledge base on drug use patterns and causes in 
ethnic minority populations.   
 
                        Major Performance Measures       Target/Timeline 
Develop research opportunities in this area 
through Program Announcements, Request for 
Applications, and/or Administrative 
Supplements 
Announcements by FY 
2002 
Increase number of studies supported Annual increases through 
FY 2005 
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research FY 2005 
Prepare the field for research in this area 
through technical assistance, resource 
materials, and meetings 
Annual activities  
Routinely monitor and discuss implementation 
progress, concerns and needs to determine if 
activities need to be modified.    This will be 
led by the Special Populations Office and the 
Health Disparities Committee with 
consultation from NIDA’s expert work groups 
and National Advisory Council’s 
subcommittee on Health Disparities. 
At least three times a year 
 
   
 Major Outcome Measures      Target/Timeline 
Increased number of studies with specific aims 
focused on the investigation of drug use, abuse 
and addiction patterns, incidence and 
prevalence in ethnic minority populations 
Annual increases through 
FY 2005 
Increased number of articles in the scientific 
literature 
Increases expected in FY 
2003 through FY 2006 
Increased number of scientific presentations Annual increases 
Development of better, culturally appropriate 
measures and procedures 
Annual progress 
Increased understanding of drug use within 
ethnic minority populations particularly as 
determined by gender, age, environment, and 
urban/rural residency 
Annual progress 
 
 
 
Objective 2:  Identify and examine issues of health disparities in drug abuse and associated 
infectious diseases particularly HIV/AIDS within racial/ethnic populations including 
analyses by gender. 
 
Action Plan 
 
Expand research to:  
 
Increase scientific knowledge about the medical and health consequences of 
HIV infections within women and men of racial/ethnic minority groups 
including assessing the magnitude, incidence and prevalence of HIV/AIDS 
and other STDs, HBV, HCV, TB, and its impact on racial/minority 
populations, identifying the associated risk and protective factors for 
HIV/AIDS and other STDs, HBV, HCV, TB, mental disorders and socio-
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 Increase amount of money supporting this            Annual increases through 
economic status (SES) among racial/minority populations, and identifying 
subgroups within racial/minority groups (e.g., homeless, homosexuals, prison 
inmates) at greatest risk. Develop and implement 
appropriate intervention strategies for reducing risk factors among women 
and men in these groups.  
 
Increase access to, utilization of, and adherence to antiviral therapies by HIV 
infected ethnic minority male and female drug users through identifying new, 
simplified, and innovative strategies/approaches and mechanisms to 
complement and improve traditional approaches for individuals in this 
population.  
 
Increase scientific knowledge on how gender and other factors such as 
community, culture, education, and SES affect HIV transmission within 
racial/ethnic populations. 
 
 Primary Outcome Measure.  The primary outcome measure is to reduce 
disparities in the medical consequences (e.g., HIV/AIDS) associated with 
drug use experienced by ethnic minority individuals.  
 
 Major Performance Measures Target/Timeline 
Develop research opportunities in this area 
through Program Announcements, Request for 
Applications, and/or Administrative 
Supplements 
Announcements by FY 
2002 
Increase number of studies supported Annual increases through 
FY 2004 
Increase amount of money supporting this 
research 
Annual increases through 
FY 2005 
Prepare the field for research in this area 
through technical assistance, resource 
materials, and meetings 
Annual activities  
Routinely monitor and discuss implementation 
progress, concerns and needs to determine if 
activities need to be modified.    This will be 
led by the Special Populations Office and the 
Health Disparities Committee with 
consultation from NIDA’s expert work groups 
and National Advisory Council’s 
subcommittee on Health Disparities. 
At least three times a year 
Coordinate with other I/Cs or agencies where 
appropriate and likely to advance the research  
On-going 
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Increased number of studies that focus on the 
investigation of HIV/AIDS and other medical 
consequences of drug involvement for ethnic 
minority populations  
Annual increases through 
FY 2004 
Increased number of articles in the scientific 
literature 
Annual increases through 
FY 2004 
Increased number of scientific presentations Annual increases 
Development of accessible and culturally 
appropriate adherence approaches  
Annual progress 
Increased understanding of the risk and 
protective factors associated with drug use and 
HIV among ethnic minority drug user 
populations particularly as determined by 
gender, age, environment, and urban/rural 
residency 
Annual increase 
 
Objective 3.   Identify both the short- and long-term effects of drug use, abuse, addiction, 
and violence and their interrelationships on the overall health (including physical, mental 
and emotional health) of men, women, and children in racial/ethnic populations.  
 
                         Action Plan 
 
 Expand research to: 
 
Identify and assess issues of co-morbidity across the age span for all 
racial/ethnic groups and the relationship between drug abuse, co-morbid 
conditions and health disparities within and across those groups and by 
gender within these groups.  
 
Investigate health and developmental disparities across racial/ethnic groups 
for children and adolescents who have experienced prenatal drug exposure 
and/or early use of illicit drugs by gender within these groups.  
 
Identify and review the state of knowledge and availability of data on the 
coexistence of substance abuse and mental/emotional disorders and the 
presence of health disparities across and within racial/ethnic groups including 
analyses by gender.  
 
Identify the impact of the drug-using environment on racial/ethnic women 
and men living under those conditions. Assess proposed strategies for 
interventions to reduce drug abuse in these groups. 
 
Evaluate the role of stress (e.g., cultural adaptation) in initiating and 
escalating drug use/abuse and its impact on various male and female 
racial/ethnic populations. Sensitivity and responsiveness of the needs of the 
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 Major Outcome Measures              Target/Timeline 
target audience must be considered in all instrument development, 
administration, analysis, and evaluation of the data.  
 
Explore the contextual relationships between drug use, violence, 
employability, school performance, family structure, and economic well 
being of the community. Sponsor a series of workshops and meetings with 
grantees and others to explore the current state of the knowledge. 
 
Primary Outcome Measure.  The primary outcome measure is to increase 
and improve the scientific knowledge base on the social, emotional, 
psychological, health, and behavioral consequences and impact of drug use 
and addiction on ethnic minority populations, identifying disparities 
experienced.  
 
 
  Major Performance Measures Target/Timeline 
Develop research opportunities in this area 
through Program Announcements, Request 
for Applications, and/or Administrative 
Supplements 
Announcements by FY 2002 
Increase number of studies supported Annual increases through FY 2005 
Increase amount of money supporting this 
research 
Annual increases through FY 2005 
Prepare the field for research in this area 
through technical assistance, resource 
materials, and meetings 
Annual activities  
Routinely monitor and discuss 
implementation progress, concerns and 
needs to determine if activities need to be 
modified.    This will be led by the Special 
Populations Office and the Health 
Disparities Committee with consultation 
from NIDA’s expert work groups and 
National Advisory Council’s subcommittee 
on Health Disparities. 
At least three times a year 
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  Major Outcome Measures  Target/Timeline 
Increased number of studies on disparities 
related to co-morbidities, environment, stress, 
and other contextual variables.   
Annual increases through 
FY 2005 
Increased number of articles in the scientific 
literature. 
Annual increases  
Increased number of scientific presentations Annual increases 
Advances in research methods and assessment 
tools related to this line of research  
Annual progress 
Increased knowledge of consequences of drug 
use and addiction specific to ethnic minority 
women and children   
Annual increases  
 
 
 
Epidemiology Research Area of Emphasis Budget 
 
   FY 2002         $4,000,000 increase (President’s Budget)* 
   FY 2003  4,200,000 (5% increase) 
   FY 2004  4,400,000 (5% increase) 
   FY 2005           4,600,000 (5% increase) 
   FY 2006  4,800,000 (5% increase) 
 
*Please note that yearly budget dollars refer to expected percent increments 
above current levels of expenditures for this area. 
 
Research Area of Emphasis 2: Prevention of Drug Abuse and Addiction 
 
This is our second research priority. 
 
NIDA has made great strides in the last few years in its prevention research program. NIDA 
has supported two long-term minority prevention research centers that focus on African 
Americans, Hispanics, and Native Americans as well as several other research projects that 
include ethnic minorities. Results from these and other research studies research suggest that 
racial/ethnic populations may have special prevention needs and prevention strategies may 
have to be specific to their culture and circumstances to be successful. For example, research 
indicates that including culturally specific components in a generic prevention program 
enhances effectiveness with African Americans.  
 
Epidemiologic data show that race/ethnic groups differ in patterns of drug use, preferences, 
and accessibility and risks requiring prevention programs that attend to these needs. For 
example, Hispanic youth are more likely to be school dropouts making school-based 
prevention programs unlikely to reach Hispanic youth at greatest risk. African Americans 
have late onset of (or delayed onset) drug use suggesting that they may be more in need of 
prevention programs after high school, in their late adolescent/early adult years. Native 
Americans on reservations need prevention programs at an early age and such programs 
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Increased number of studies focusing on specific prevention 
needs of each ethnic minority populations  
must be acceptable to tribal councils. Second generation immigrants may be at higher risk 
for drug use than first generation. Moreover, the heterogeneity or diversity within 
racial/ethnic groups must be acknowledged in prevention efforts, e.g., gender, SES, 
education, cultural styles, rural-urban, and the specific risk factors for these subgroups need 
to be better understood to inform prevention efforts.  
 
More prevention programs are needed to reach minority populations in high-risk settings 
and neglected, hard-to-reach areas or communities. This includes, for example, persons in 
correctional facilities (more likely to be African Americans and Hispanics), persons in rural 
areas, migrant workers/seasonal farm workers (often Hispanic and Haitian), children in drug 
abusing families, and minority women addicts (who are at great risk for infectious diseases). 
More research is needed on prevention efforts with Asian/ Pacific Islanders and Native 
Americans/Alaska Natives and their subgroups.  
 
Objective 1. Support prevention research targeting racial/ethnic minorities to: (1) 
understand the drug abuse and HIV/AIDS prevention needs of minority populations across 
the life span with specific attention to very early and late onset initiation of use and diversity 
in vulnerability to use across the life cycle, e.g., immigrant groups adapting to new 
environment, transition points, stress; (2) understand how to develop culturally appropriate 
prevention interventions and how to adapt "generic" prevention models for specific minority 
populations; (3) examine the effectiveness of mass media  prevention/education messages 
that target specific minority populations; (4) develop more prevention interventions that 
reach minority populations in contexts such as the family, church/faith community, and 
other community programs to ensure that prevention expertise becomes a permanent part of 
the community; (5) address the complexities and requirements of developing effective 
prevention programs for diverse groups within multiethnic, multicultural settings, e.g., 
schools with multiethnic student bodies, persons with multiple ethnic identification or 
affiliations, and (6) identify how cultural norms affect gender differences in drug use and 
risk factors. 
 
          Action Plan:  
 
         Develop research opportunities in the above areas. 
 
Primary Outcome Measure. The primary outcome measure is to improve 
the scientific knowledge base on the factors that contribute to effective 
prevention interventions for ethnic minority populations.   
 
   Major Outcome Measures     Target/Timeline 
Annual increases through FY 2005 
Increased number of articles in the scientific literature
Increased number of scientific presentations Annual increases 
Increased number and/or refinement of prevention 
strategies/models  
Annual progress 
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Annual increases 
 
Objective 2. Ensure that racial/ethnic minority populations are fully incorporated into the     
planning and implementation of NIDA's next generation of prevention research initiative.  
(The Next Generation of Prevention Research is an initiative designed to gain a better 
understanding of the factors that account for prevention program effectiveness.)  
 
         Action Plan:  
 
NIDA staff will review plans for the next generation studies to make certain 
that concerns of racial/ethnic minorities are adequately addressed. 
 
Primary Outcome Measure.  The primary outcome measure is the adequate 
representation of ethnic minority issues and populations in this major 
prevention initiative.   
 
Major Performance Measures Target/Timeline 
Encourage research applications in this initiative Continuing with formal 
announcement of initiative  
Require the inclusion of ethnic minority issues 
and populations in research supported through 
this initiative  
Continuing  
Monitor inclusion of minority populations in the 
studies 
Continuing  
 
 Major Outcome Measures  Target/Timeline 
 Adequate inclusion of ethnic minority 
populations and issues in prevention 
effectiveness research trials 
 
Increased articles in the scientific literature on 
prevention effectiveness with ethnic minority 
populations 
 
Increased number of scientific presentations   
Better understanding of process and factors 
necessary to develop effective prevention 
programs for ethnic minority groups   
 
 
Objective 3. Develop effective, culturally specific drug abuse prevention strategies for 
minority populations who are at increased risk for drug abuse such as individuals in 
detention or correctional facilities, the homeless, and persons who have been abused or 
neglected, and those groups who are underserved such as those living on Indian reservations 
or in rural areas and migrants or seasonal farm workers, and youth in the early stages of 
cultural adaptation and acculturation.  
 
          Action Plan:  
 
             Expand research opportunities in this area. 
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Primary Outcome Measure.  The primary outcome measure is to reduce 
disparities in prevention efforts available to ethnic minority populations who 
are underserved or at increased risk for drug abuse and addiction.   
 
    
 Major Outcome Measures     Target/Timeline 
Increased number of studies that focus on 
prevention with ethnic minority populations at 
higher risk for drug abuse and addiction and its 
consequences 
Annual increases through 
FY 2005 
Increased number of articles in the scientific 
literature 
Annual increases 
Increased number of scientific presentations  Annual increases 
Development/Refinement of prevention 
strategies specifically for higher risk 
individuals  
Annual progress 
 
Prevention Research Area of Emphasis Budget 
 
 Budget: FY 2002         $4,000,000 increase (President’s Budget)* 
   FY 2003  4,200,000 (5% increase) 
   FY 2004  4,400,000 (5% increase) 
   FY 2005           4,600,000 (5% increase) 
   FY 2006  4,800,000 (5% increase) 
 
*Please note that yearly budget dollars refer to expected percent increments 
above current levels of expenditures for this area. 
 
 
Research Area of Emphasis 3: Addressing Disparities in Treatment and Health 
Services Research 
 
This is our third research priority.  
 
NIDA currently supports several activities that focus on racial/ethnic groups and cultural 
factors in treatment for addiction. For example, the Behavioral Therapy Development 
Program supports several studies that are evaluating family-based treatment approaches for 
drug using minority youth (based on research findings suggesting that family variables are 
more influential in substance use in certain minority youth). Some of these studies suggest 
that treatment engagement procedures may be different for Mexican American and Cuban 
youth. Analyses will be conducted to ascertain whether outcome differences are due to 
cultural factors associated with Mexican-American and Cuban families or other factors. A 
study was funded that is evaluating the efficacy of adding a culturally-relevant, community-
based community reinforcement enhancement to an existing residential treatment program 
for homeless, crack-using, African-American women with children. This study is using the 
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Black church as a vehicle for implementing the intervention. To advance the current 
knowledge base about potential ethnic differences in nicotine dependence, NIDA is 
supporting a study that will design and test the efficacy of smoking cessation programs in 
treating Chinese American smokers.  
 
NIDA's newly established National Drug Abuse Treatment Clinical Trials Network (CTN) 
will provide yet another vehicle for NIDA to ensure that minority populations are included 
in both NIDA's treatment research protocols and in actually conducting treatment research. 
The CTN will provide a much-needed national research and dissemination infrastructure to 
more rapidly and systematically bring new science-based addiction treatments into real-life 
treatment settings.  
 
Considering the severe consequences of drug abuse and addiction on racial/ethnic 
populations, NIDA realizes that minority populations need to be more fully included in 
treatment research and clinical trials. Moreover, more attention needs to be directed at 
examining medical, social, and cultural factors that may influence adherence to treatment 
and treatment outcomes. For example, some minority populations are included in NIDA 
supported clinical trials of pharmacotherapies and behavioral therapies; however, data are 
not completely analyzed by race/ethnicity to better understand behavior in treatment or 
outcomes of treatment. In some clinical research studies, there have been difficulties in 
enrolling and retaining adequate numbers of minorities in order to conduct meaningful data 
analyses. Other research indicates that race/ethnicity may be important in physiological 
responsiveness to drugs. For example, pharmacokinetic studies indicate that there are 
differences in some ethnic populations in their ability to metabolize different drugs.  
 
Racial/ethnic minorities may experience more difficulties in obtaining the most appropriate 
health care services. Research suggests that they may be more vulnerable to gaps and lack of 
coordination in systems of care and that they may encounter bias in treatment assignments. 
The need for services appears to differ by race/ethnicity, e.g., one study suggests that 
Latinos may require more intensive services.  
 
Objective 1. Increase the number of treatment research studies that focus on racial/ethnic 
 differences and improve dissemination of the study results.  
 
          Action Plan:  
 
Ensure that all racial/ethnic minority populations are fully included in 
NIDA's newly established National Drug Abuse Treatment Clinical Trials 
Network (CTN) as clients, advisors, and research staff. Ensure that a 
sufficiently large sample is recruited in each study to allow for analyses by 
specific racial/ethnic groups.  
 
Develop a strategy to obtain more input from minority populations for the 
NIDA research agenda.  
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Encourage research to develop and test behavioral treatments that are 
culturally- and gender sensitive and relevant for racial/ethnic minorities; and 
encourage studies of behavioral treatments, alone and in combination with 
pharmacological treatments, for racial and ethnic minority drug abusers, 
including adolescents, women, and those involved with the criminal justice 
system.  
 
Develop systems to encourage NIDA grantees to include sufficient numbers 
of minority populations, to analyze the data that are collected on racial/ethnic 
minorities, and to publish the results.  
 
Encourage research to develop validated, reliable clinical screening and 
assessment instruments in languages other than English for use in clinical 
research with non-English speaking subjects.  
 
Expand NIDA's intramural clinical research to address treatment issues by 
race/ethnicity, and further develop the program focusing on smoking 
cessation techniques with minority youth.  
 
Sponsor a series of workshops and meetings with grantees and the minority 
advisory groups to explore the current state of knowledge, identify gaps in 
the research, and make recommendations for future research. The 
professional organizations representing different minority populations should 
also participate in this process.  
 
Primary Outcome Measure.  The primary outcome measures are to increase 
the inclusion of ethnic minority populations in treatment research and 
improve the validity and appropriateness of the research for ethnic minority 
populations. 
  
 Major Performance Measures    Target/Timeline 
Institute procedures for the adequate inclusion of 
ethnic minority issues and populations in the CTN  
By FY 2003  
Develop research opportunities through Program 
Announcements, Request for Applications, and/or 
Administrative Supplements 
By FY 2004 
Implement strategies to solicit input from the field Ongoing 
Implement procedures to improve assessment tools By FY 2003 
Routinely monitor and discuss implementation 
progress, concerns and needs to determine if 
activities need to be modified.  This will be led by 
the Special Populations Office and the Health 
Disparities Committee with consultation from 
NIDA’s expert work groups and National Advisory 
Council’s subcommittee on Health Disparities 
At least three times a 
year 
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 Major Outcome Measures     Target/Timeline 
Increased number of studies that focus on 
effective clinical interventions with ethnic 
minority individuals 
Annual increases through 
FY 2005 
Clinical tools available in languages other than 
English 
By FY 2004 
Expanded research agenda that reflects needs 
of the field  
Ongoing 
Increased number of scientific presentations Annual increases 
Increased number of articles in the scientific 
literature 
Annual increases 
 
 
Objective 2. Determine the factors that contribute to differences, if any, experienced by 
racial/ethnic minority populations in access to services and outcomes of treatment in 
managed care and other service systems. In addition, assess the impact of welfare reform 
on substance abuse services provided to ethnic minorities especially minority women.  
 
          Action Plan:  
 
Expand the treatment and prevention services research portfolio to better 
understand the organization, management, financing and delivery of services 
and to enhance the integration of treatment and prevention strategies and 
programs into existing community level service delivery systems.  
 
Sponsor a series of workshops and meetings with grantees and the minority 
advisory groups to explore the current state of knowledge, identify gaps in 
the research, and make recommendations for future research. The 
professional organizations representing different minority populations should 
also participate in this process.  
 
Primary Outcome Measure.  The primary outcome measure is the reduction 
of disparities in drug treatment services experienced by ethnic minority 
populations.   
  
 Major Performance Measures    Target/Timeline 
Develop research opportunities in this area through Program 
Announcements, Request for Applications, and/or Administrative 
Supplements 
By FY 2004 
 
Increase number of studies supported By FY 2005 
Encourage and prepare the field for research in this area Ongoing 
Routinely monitor and discuss implementation progress, concerns 
and needs to determine if activities to be modified.  This will be led 
by the Special Populations Office and the Health Disparities 
Committee with consultation from NIDA’s expert work groups and 
National Advisory Council’s Subcommittee on Health Disparities.   
At least three 
times a year 
Provide forum/opportunities for the field to build research agenda   Ongoing 
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 Major Outcome Measures     Target/Timeline 
Increased number of studies  Annual increases 
Increased number of professional presentations Annual increases 
Expanded research agenda Ongoing 
Better understanding of factors that contribute 
to disparities in drug treatment and services for 
each ethnic minority population 
Annual progress 
 
Treatment and Services Research Area of Emphasis Budget 
 
 Budget: FY 2002         $6,000,000 increase (President’s Budget)* 
   FY 2003  6,300,000 (5% increase) 
   FY 2004  6,600,000 (5% increase) 
   FY 2005           6,900,000 (5% increase) 
   FY 2006  7,200,000 (5% increase) 
 
*Please note that yearly budget dollars refer to expected percent increments 
above current levels of expenditures for this area. 
 
 
Research Area of Emphasis 4: Addressing Racial/Ethnic Disparities in Basic and    
Clinical Neurosciences 
  
This is our fourth research priority area. 
 
Research is needed to better understand racial/ethnic differences in genetic vulnerability 
and/or resilience to drug abuse and addiction; neurotoxicity; and neurobiological and 
behavioral processes underlying tolerance, dependence, and relapse. Pharmacokinetic 
studies have revealed distinct differences in some ethnic populations in the ability to 
metabolize different drugs, indicating a clear biological basis in response to drugs. Studies 
focusing on the interaction between racial/ethnic differences and the effects of drugs on 
underlying neural and behavioral processes will provide the basis for more targeted 
treatment and prevention approaches in different populations.  
 
Objective 1: Increase the number of neuroscience, clinical neuroscience, and basic 
behavioral science studies that focus on racial/ethnic differences.  
 
          Action Plan: 
 
Provide support to key investigators to over sample under-represented groups 
in their studies. 
 
Require NIDA program staff to emphasize the importance of inclusion of 
minority subjects to all Principal Investigators conducting human subject 
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research and to work closely with those who are deficient in their minority 
recruitment.  
 
Provide avenues for publication of basic research findings comparing sub-
groups, including NIDA sponsored publications such as NIDA monographs.  
 
Provide information on strategies for recruiting under-represented groups into 
basic human subject based research.  
 
Expand research that directly targets minorities in the basic and clinical 
neurosciences and behavioral sciences, with the intent of addressing minority 
health disparities  
  
Primary Outcome Measure.  The primary outcome measure is the 
improvement of our understanding of any neurobiological effects associated 
with drug use in ethnic minority populations, noting especially disparate 
processes and effects.  
 
 
 Major Performance Measures    Target/Timeline 
Develop research opportunities in this area 
through Program Announcements, Request for 
Applications, and/or Administrative 
Supplements 
By FY 2003 
Increase number of studies supported By FY 2004 
Increase amount of money supporting this 
research 
FY 2003 
Prepare the field for research in this area 
through technical assistance, resource 
materials, and meetings 
Ongoing 
Routinely monitor and discuss implementation 
progress, concerns and needs to determine if 
activities need to be modified.  This will be led 
by the Special Populations Office and the 
Health Disparities Committee with 
consultation from NIDA’s expert work groups 
and National Advisory Council’s 
Subcommittee on Health Disparities 
At least three times a year 
 
 
 
 
 
 
 
 
 19
 
 Major Outcome Measures Target/Timeline 
Increased number of studies  Annual starting in FY 
2004 
Better understanding of genetic and 
neurobiological factors associated with 
addiction  
Annual progress 
Increased number of articles in the scientific 
literature  
Annual increases starting 
in FY 2004 
Increased number of scientific presentations Annual increases starting 
in FY 2004 
Better informed researchers and practitioners Annual progress 
 
Neuroscience Research Area of Emphasis Budget 
 
 
 Budget: FY 2003  2,000,000 (increase in President’s Budget)* 
   FY 2004  2,100,000 (5% increase) 
   FY 2005           2,200,000 (5% increase) 
   FY 2006  2,300,000 (5% increase) 
 
*Please note that yearly budget dollars refer to expected percent increments 
above current levels of expenditures for this area. 
 
 
Goal 2.   Research Capacity (Infrastructure Development)  
 
Research capacity is our first overall priority. 
 
NIDA recognizes that conducting scientifically valid health disparities research requires a 
research infrastructure that includes well-informed and trained scientists, knowledgeable and 
cooperative communities (e.g., community-based organizations, professional associations, 
faith community, tribal councils), and academic institutions with competency and interest in 
health disparities research. NIDA has made concerted efforts to build this critical 
infrastructure for health disparities research. We have worked to increase the number of 
underrepresented scholars involved in drug abuse research and to increase our support of 
useful and appropriate research on drug abuse in minority communities. A number of 
initiatives, programs and activities have been implemented to eliminate this 
underrepresentation, for example, the establishment of expert work groups on racial/ethnic 
populations, the strengthening of the Minority Supplement Program, the development of an 
HBCU Initiative, the provision of technical assistance in grants development, and the 
development of program announcements and RFAs to build the minority research 
infrastructure. NIDA plans to build upon these already successful programs and expand 
them to increase training and career development opportunities for underrepresented 
minorities. In addition, NIDA plans to increase the numbers of researchers and research 
studies that focus on abuse and addiction in minority communities and to, in general, 
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stimulate interest and enhance competency in conducting research for eliminating disparities 
experienced by racial/ethnic populations related to drug abuse and addiction.  
 
Objective 
 
Ensure proper resource requirements through training/career development for students, 
faculty and investigators, academic institutions, and professionals and communities. 
 
  Action Plan   
 
Student Development and Support. NIDA will continue to support its current 
activities to increase the number of underrepresented students entering drug 
abuse research careers. This includes the Minority Recruitment and Training 
program sponsored by the intramural program, the extramural Summer 
Research with NIDA program for minority high school and undergraduate 
students, and the Minority Supplement program. In addition:  
 
NIDA will encourage applications for short-term training grants (T35) from 
drug abuse and addiction programs particularly those involved in the 
National Drug Abuse Clinical Trials Network (CTN) to offer summer 
research training experiences for promising undergraduate and graduate 
minority students.  
 
          Faculty and Investigator Development.  
 
NIDA will continue to support its current activities to increase the number of 
faculty and scholars conducting drug abuse and addiction research. This 
includes the Minority Supplement Program, the Research Development 
Technical Assistance program, and the on-line research grants development 
program. In addition, NIDA will:  
 
Develop a Visiting Scholar Program to recruit and train African American, 
Hispanic and other minority drug abuse researchers with a special outreach to 
scholars from minority programs and institutions such as HBCUs, HSIs and 
tribal colleges to spend time in selected research programs learning state-of-
the-art methodology. The small grant mechanism (R03) could be used to 
support a period of training in laboratories using state-of-the-art technologies 
to examine a variety of aspects of drug abuse and addiction.  
 
Develop a Career Development Award (K01) for minority faculty interested 
in all areas of drug abuse and addiction research. This program would be 
aimed at faculty seeking a period of protected time to devote to developing 
drug abuse research projects at their institutions. Special efforts will be 
undertaken to increase the number of minority researchers in prevention and 
clinical research.  
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Establish a Minority Clinical Research Scholars Program in the NIDA 
Intramural Research Program.  
 
Develop a plan with the Center for Substance Abuse Treatment to bring more 
minority scientists into drug abuse and addiction clinical research. Explore 
the possibility of supporting minority supplement grants on CSAT research 
and evaluation projects.  
 
Establish a Minority Clinical Research Scholars Fellowship as part of NIDA's 
CTN program.  
 
Academic Institution Development. 
 
NIDA will continue its efforts to increase the capacity of academic 
institutions, especially minority colleges and universities, to conduct drug 
abuse research. This includes the Minority Institutions Drug Abuse Research 
Program and the HBCU Initiative. In addition, NIDA will:  
 
Develop partnerships between institutions with well-established drug abuse 
research programs and minority institutions that are interested in developing 
capacity in this area. Collaborate with ORMH on plans to establish 
partnerships between drug abuse research centers and minority institutions.  
 
Establish a NIDA Minority Access to Drug Abuse Research Careers Program 
through the National Research Services Act (NRSA) to encourage and 
engage promising minority undergraduate scientists in drug abuse and 
addiction research.  
 
Support or examine the possibility of establishing Training Centers (T32s) in 
the basic neurosciences and behavioral sciences, and clinical neurosciences at 
HBCUs and other minority education-oriented colleges and universities. 
Encourage the participation of minority students at already existing centers.  
 
              Professional and Community Development  
 
NIDA will continue its efforts to involve the broader community in 
addressing health disparities in racial/ethnic communities caused by drug 
abuse and addiction. This includes the various expert work groups on African 
American, Hispanic, Asian American and Pacific Islander, and Native 
American and Alaska Native communities. In addition, NIDA will:  
 
Encourage clinical minority professional organizations to create and 
administer clinical minority research development programs through the K12 
mechanism. This can be modeled after the successful American Psychiatric 
Association and American Academy of Child and Adolescent Psychiatry 
 22
programs to recruit and train minority clinicians interested in drug abuse and 
addiction research.  
 
Host a series of writing workshops to facilitate publications in peer reviewed 
journals by minority scholars.  
 
Develop opportunities (e.g., forums at professional meetings) to discuss drug 
abuse research needs, plans, and opportunities with key stakeholder groups to 
include practitioners and consumers.  
 
Support workshops or programs to train investigators on conducting 
responsible drug abuse research in racial/ethnic minority communities. 
Consider creating guidelines for ensuring that such research is appropriate 
and sensitive.  
   
Primary Outcome Measure.  The primary outcome measure is a significant 
increase in well-informed and trained scientists engaged in minority and 
health disparities research in drug abuse.   
 
Major Performance Measures    Target/Timeline 
Develop research development opportunities 
through Program Announcements, Request for 
Applications, Minority Supplement Program, 
and/or Administrative Supplements  
Start by FY 2002 
Increase budget to support these initiatives Annual increases 
Collaborate with other I/Cs and agencies on 
programs/activities of mutual interest 
Ongoing 
Prepare the field to pursue drug abuse research 
in minority health and health disparities areas  
Ongoing 
Routinely monitor and discuss implementation 
progress, concerns and needs to determine if 
activities need to be modified.  This will be led 
by the Special Populations Office and the 
Health Disparities Committee with 
consultation from NIDA’s expert work groups 
and National Advisory Council’s 
subcommittee on Health Disparities 
At least three times a year 
 
 Major Outcome Measures     Target/Timeline 
Increased involvement of minority institutions 
in drug abuse research on minority populations 
and health disparities, e.g., more grants, 
collaboration with grantees  
Annual increases 
Increased number of minority investigators  Annual increases 
Increased number of investigators researching 
minority and health disparities issues in drug 
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abuse and addiction 
Increased number of students pursuing careers 
in drug abuse research 
Annual increases 
Availability of new programs to support ethnic 
minority students and faculty 
 
Increased participation in meetings and forums 
(to disseminate information on research 
development needs and opportunities)  
Ongoing  
 
  Research Capacity Budget  
 
 Budget: FY 2002         $2,000,000 (increase in President’s Budget)* 
   FY 2003  2,100,000 (5% increase) 
   FY 2004           2,200,000 (5% increase) 
   FY 2005  2,300,000 (5% increase) 
    FY 2006 2,400,000 (5% increase) 
 
*Please note that yearly budget dollars refer to expected percent increments 
above current levels of expenditures for this area. 
 
 
Goal 3. Community Outreach, Information Dissemination, and Public Health 
Education   
 
This is our third overall priority. 
 
There are special challenges and problems in creating culturally appropriate information for 
special populations. To meet these challenges NIDA has organized and convened ethnic 
advisory panels for Latinos, Asian-Americans/Pacific Islanders (AAPIs), and African 
Americans to improve our outreach to these various ethnic and minority groups. Acting 
upon the advise of these experts, NIDA has:  
 
Developed Spanish translations of our two popular marijuana pamphlets, 
"Marijuana: Facts for Teens" and "Marijuana: Facts Parents Should Know"  
Created a radio Public Service Announcement campaign on marijuana abuse for 
African American males aged 13-25 Produced over 30 fact sheets about drug abuse 
and addiction in Spanish as part of our fax-back system, "INFOFAX" Marketed the 
"INFOFAX" series as well as the NIDA web site via a Spanish art card distributed to 
appropriate outlets nationally  Given financial and editorial support to "Pro Salud," a 
national publication marketed to Hispanic communities, Developed Spanish 
translations of the drug abuse Problem Oriented Screening and Assessment 
Instrument for adolescents.  
 
In addition to these efforts, NIDA routinely distributes all of its press releases to media 
outlets designed to reach special populations.  
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Objective 1: Educate racial/ethnic minority populations about drug abuse and addiction 
prevention and treatment. Also, identify and improve mechanisms for dissemination of 
research findings within and across minority groups. NIDA is focusing on four key cultural 
minorities at present, Asian Americans/Pacific Islanders, Hispanic, Native Americans, and 
African Americans. Based on discussions with members of our cultural minority advisory 
panels, we have also identified some subpopulations with special needs (e.g., Vietnamese, 
Cambodian, Filipino, other Pacific Islander).  
 
             Action Plan:  
 
Develop a series of radio PSAs and educational videos targeting Hispanic 
women. Hispanic women have a strong influence in health and lifestyle 
decisions within the Hispanic community. In addition to PSAs, a Hispanic 
family-targeted brochure and video highlighting specific drugs of abuse 
known to be a problem in various Hispanic communities (as well as among 
mainstream youth) will be provided as collateral materials. A comprehensive 
marketing plan to get the PSAs aired and the brochure distributed includes 
forming partnerships with appropriate Hispanic organizations and persons of 
influence (journalists, entertainers, etc.). NIDA will work closely with the 
NIH Hispanic Initiative Coordinator during the preparation of all related 
materials.  
 
Create a year 2001 calendar for Native Americans that will be used to 
provide information about drug abuse. It will be marketed broadly in the fall 
2000 via appropriate organizations, the media and other venues (e.g., Native 
American-owned businesses; Indian Health Service clinics).  
 
Create television drug abuse PSAs and videos in Spanish which will be 
distributed to appropriate Hispanic outlets. The PSAs and videos will follow 
the theme of NIDA's national campaign, "Addiction is a Brain Disease," in an 
effort to educate the Hispanic community about the disease of addiction.  
 
Translate and adapt other popular NIDA publications into Spanish including, 
"Principles of Drug Addiction Treatment". When completed, these materials 
will be packaged as a comprehensive set and broadly distributed to Hispanic-
oriented schools, health organizations, and community groups. Provide 
targeted training to Hispanic substance abuse treatment providers on effective 
treatment methods.  
 
Enhance NIDA collaboration with minority professional organizations 
through the NIDA Constituent Conference, NIDA Town Meetings, etc.  
 
Primary Outcome Measure.  The primary outcome measure is the 
production of general audience materials and dissemination strategies that 
educate each ethnic minority community about drug abuse in a scientifically 
accurate and culturally appropriate manner.    
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                        Major Performance Measures    Target/Timeline 
Develop materials specific to the audience as 
indicated in the plan  
Ongoing 
Consult with experts on communication and 
ethnic minority populations  
Ongoing 
Routinely monitor and discuss implementation 
progress, concerns and needs to determine if 
activities need to be modified.  This will be led 
by the Special Populations Office and the 
Health Disparities Committee with 
consultation from NIDA’s expert work groups 
and National Advisory Council’s 
subcommittee on Health Disparities 
At least three times a year 
 
 Major Outcome Measures     Target/Timeline 
Materials available in Spanish Ongoing 
Established ongoing relationships with various 
ethnic minority constituent groups 
Ongoing 
Dissemination plans for Hispanic and Native 
American populations available  
By FY 2004 
Calendars prepared for Native Americans 
available 
Annual  
 
Objective 2.  Put research into practice in minority communities by providing science-based 
prevention and treatment information to service providers serving these populations.  
 
          Action Plan:  
 
Translate "Preventing Drug Use Among Children and Adolescents: A 
Research-Based Guide" and "Principles of Drug Addiction Treatment: A 
Research-Based Guide" into Spanish and distribute them to care givers and 
service providers who work with Hispanic populations.  
 
Distribute to service providers working in minority communities the "NIDA 
Toolkit." The "NIDA Toolkit" is a national NIDA initiative to get the latest 
treatment information, including a set of NIDA Treatment Manuals to service 
providers across the Nation.  
 
Develop an outreach program to community leaders of specific special 
populations groups that will enable them to help families understand drug 
abuse problems within their communities and give those families the 
culturally appropriate tools for prevention and treatment in those 
communities.  
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Translate the NIDA treatment manuals into Spanish and distribute them to 
treatment providers who work with minority populations.  
 
Develop a research-based prevention guide for persons working with 
racial/ethnic minority groups.  
 
Primary Outcome Measure.  The primary outcome measure is the 
availability of research-based drug abuse materials and tools on ethnic 
minority populations for health care providers and researchers. 
 
Major Performance Measures   Target/Timeline 
Develop the materials as outlined in the plan By FY 2004 
Distribute the materials to service providers 
and community leaders working with ethnic 
minority populations 
By FY 2005 
Routinely monitor and discuss implementation 
progress, concerns and needs to determine if 
activities need to be modified.  This will be led 
by the Special Populations Office and the 
Health Disparities Committee with 
consultation from NIDA’s expert work groups 
and National Advisory Council’s 
subcommittee on Health Disparities 
At least three times a year 
 
 Major Outcome Measures       Target/Timeline 
Availability of guides and manuals in other 
languages 
By FY 2005 
Culturally appropriate outreach program 
available 
By FY 2006 
 
 
Objective 3. Educate the research and practice community about the state-of-the-art in drug 
abuse and addiction research with racial/ethnic minority populations.  
  
          Action Plan:  
 
Sponsor a national conference on drug abuse and addiction research and 
racial/ethnic communities.  
 
Develop a guide and web site where information on research with 
racial/ethnic populations is available. Information such as current research, 
research findings, and valid measures would be available.  
 
Provide guidelines and training on how to conduct research with racial/ethnic 
groups including information on cultural styles and ethical issues.  
 
Identify and improve mechanisms for dissemination of research findings 
within and across minority groups.  
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Primary Outcome Measure.  The primary outcome measure is the increase 
in the cadre of researchers and practitioners knowledgeable about ethnic 
minority and health disparities research in drug abuse and addiction.  
 
 Major Performance Measures    Target/Timeline 
Convene the national conference FY 2001 
Develop information sources as outlined Annual progress 
Routinely monitor and discuss implementation 
progress, concerns and needs to determine if 
activities need to be modified.  This will be led 
by the Special Populations Office and the 
Health Disparities Committee with 
consultation from NIDA’s expert work groups 
and National Advisory Council’s 
subcommittee on Health Disparities 
At least three times a year 
 
 Major Outcome Measures        Target/Timeline 
Increase in persons informed about drug abuse 
research in ethnic minority populations  
Ongoing 
Availability of easily accessible information on 
drug abuse research in ethnic minority 
communities (web-based information) 
By FY 2003 
Increased interaction of NIDA staff with 
students, researchers, and practitioners 
interested in drug abuse research 
Ongoing  
Better trained/prepared researchers pursuing or 
conducting drug abuse research in ethnic 
minority communities 
Ongoing 
Increased use of NIDA as a resource  Ongoing 
 
Public Information Budget  
 
 Budget: FY 2002         $1,000,000 (increase in President’s Budget)* 
   FY 2003  1,050,000 (5% increase) 
   FY 2004           1,100,000 (5% increase) 
   FY 2005  1,150,000 (5% increase) 
    FY 2006 1,200,000 (5% increase) 
 
*Please note that yearly budget dollars refer to expected percent increments 
above current levels of expenditures for this area. 
(Nov. 2001) 
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   NIDA Health Disparities Budget   
   (Dollars in Millions)   
        
        
FY 2002 FY 2003 
Institute/Center  Research Infrastructure Outreach Research Infrastructure Outreach 
NIDA $26.50 $2.00 $1.00 $28.90 $2.10 $1.10 
 
